Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: A meta-analysis of randomized controlled trials

American Journal of Clinical Nutrition

Volumn 89, Issue 1, 2009, Pages 77-84

  Bai, Yongyi ^a   Sun, Lan ^b   Yang, Tao ^a   Sun, Kai ^a   Chen, Jingzhou ^a   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PLACEBO;

ARTICLE; BLOOD FLOW; CALCULATION; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; HUMAN; REGRESSION ANALYSIS; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

ADMINISTRATION, ORAL; ADULT; AGED; ARGININE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CHILD; ENDOTHELIUM, VASCULAR; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGIONAL BLOOD FLOW; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION; YOUNG ADULT;

EID: 58149389277     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26544     Document Type: Article

References (50)

1. Report WH. Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002.
2. Perez-Vizcaino F, Duarte J, Andriantsitohaina R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 2006;40:1054-65.
3. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-4.
4. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
5. Wang J, Brown MA, Tam SH, et al. Effects of diet on measurements of nitric oxide metabolites. Clin Exp Pharmacol Physiol 1997;24:418-20.
6. Huggins G.S, Pasternak RC, Alpert NM, et al. Effect of short term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 1998;98:1291-6.
7. Lerman A, Suwaidi JA, Velianou JL. l-Arginine: a novel therapy for coronary artery disease? Expert Opin Investig Drugs 1999;8:1785-93.
8. Tousoulis D, Böger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Mechanisms of disease: L-arginine in coronary atherosclerosisa clinical perspective. Nat Clin Pract Cardiovasc Med 2007;4:274-83.
9. Stanislavov R, Nikolova V, Rohdewald P. Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial. Int J Impot Res 2008;20:173-80.
10. Miller AL. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Altern Med Rev 2006;11:23-9.
11. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997;129:261-9.
12. Hambrecht R, Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000;35:706-13.
13. Blum A, Hathaway L, Mincemoyer R, et al. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000;101:2160-4.
14. Maxwell AJ, Zapien MP, Pearce GL, MacCallum G, Stone PH. Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol 2002;39:37-45.
15. Bennett-Richards KJ, Kattenhorn M, Donald AE, et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int 2002;62:1372-8.
16. Bode-Böger SM, Muke J, Surdacki A, Brabant G, Böger RH, Frölich JC. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 2003;8:77-81.
17. Yin WH, Chen JW, Tsai C, Chiang MC, Young MS, Lin SJ. L-Arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr 2005;24:988-97.
18. Siasos G, Tousoulis D, Vlachopoulos C, et al. Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals. Int J Cardiol 2008;126:394-9.
19. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-Arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation 2007;116:188-95.
20. Marchesi S, Lupattelli G, Siepi D, et al. Oral L-arginine administration attenuates postprandial endothelial dysfunction in young healthy males. J Clin Pharm Ther 2001;26:343-9.
21. Martina V, Masha A, Gigliardi VR, et al. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 2008;31:940-4.
22. Lin CC, Tsai WC, Chen JY, Li YH, Lin LJ, Chen JH. Supplements of L-arginine attenuate the effects of high-fat meal on endothelial function and oxidative stress. Int J Cardiol 2008;127:337-41.
23. Hirooka Y, Egashira K, Imaizumi T, et al. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol 1994;24:948-55.
24. Angdin M, Settergren G, Liska J, Astudillo R. No effect of L-arginine supplementation on pulmonary endothelial dysfunction after cardiopulmonary bypass. Acta Anaesthesiol Scand 2001;45:441-8.
25. Bode-Böger SM, Böger RH, Alfke H, et al. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: a randomized, controlled study. Circulation 1996;93:85-90.
26. Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. J Am Coll Cardiol 1998;32:904-11.
27. Pernow J, Bohm F, Beltran E, Gonon A. L-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol 2003;95:2218-22.
28. Piatti P, Fragasso G, Monti LD, et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003;107:429-36.
29. Hirooka Y, Imaizumi T, Tagawa T, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658-68.
30. Walker HA, McGing E, Fisher I, et al. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 2001;38:499-505.
31. Rector TS, Bank AT, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-41.
32. Regensteiner JG, Popylisen S, Bauer TA, et al. Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes. Vasc Med 2003;8:169-75.
33. Koga Y, Akita Y, Junko N, et al. Endothelial dysfunction in MELAS improved by L-arginine supplementation. Neurology 2006;66:1766-9.
34. Sozykin AV, Noeva EA, Balakhonova TV, Pogorelova OA, Men'shikov MI. Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris. Ter Arkh 2000;72:24-7.
35. Clarkson P, Adams MR, Powel AJ, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996;97:1989-94.
36. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol 1995;26:1054-61.
37. Abdelhamed AI, Reis SE, Sane DC, Brosnihan KB, Preli RB, Herrington DM. No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia. Am Heart J 2003;145:E15.
38. Böger GI, Rudolph TK, Maas R, et al. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: effect of combination with oral L-arginine. J Am Coll Cardiol 2007;49:2274-82.
39. Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13.
40. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
41. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
42. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
43. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychol Bull 1979;86:638-41.
44. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: relation to vessel wall morphology. Circulation 1994;89:1615-23.
45. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
46. Otsuji S, Nakajima O, Waku S, et al. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis. Am Heart J 1995;129:1094-100.
47. Besset A, Bonardet A, Rondouin G, Descomps B, Passouant P. Increase in sleep related GH and Prl secretion after chronic arginine aspirate administration in man. Acta Endocrinol (Copenh) 1982;99:18-23.
48. Elsair J, Khelfat K, Ghouini A, Ikhlef F. Effects of arginine, administered orally, on the endogenous secretion of the STH-somatomedin complex in young human volunteers. C R Seances Soc Biol Fil 1985;179:608-14.
49. Isidori A, Lo Monaco A, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Curr Med Res Opin 1981;7:475-81.
50. Hayde M, Vierhapper H, Lubec B, et al. Low-dose dietary L-arginine increases plasma interleukin 1 alpha but not interleukin 1 beta in patients with diabetes mellitus. Cytokine 1994;6:79-82.